Effects of Nasal-spraying LiveSpo Navax in Treatment of Influenza Virus in Children

Launched by NATIONAL CHILDREN'S HOSPITAL, VIETNAM · May 12, 2022

Keywords

ClinConnect Summary

Influenza virus types A and B is the common virus that causes Acute Respiratory Tract Infections (ARTIs) with a high risk of bronchiolitis for young children and infants. Influenza-infection symptoms range from mild fever, cough, runny nose, and wheezing to severe symptoms such as fast pulse, fast breathing, and respiratory failure. In a systematic review and meta-analysis of the global burden of seasonal influenza respiratory infections in young children, they estimated that 28.000 - 111.500 children under the age of 5 die as a result of influenza infections in 2008, of which 99% of these ...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Children (male/female) aged from 4 months to 7 years
• • Admitted to hospital due to upper respiratory infection
• • Influenza A and B positive by rapid test
• • Parents of the pediatric patient agree to participate in the study, explain and sign the research consent form.
• Exclusion Criteria:
• • Newborn babies
• • Having a history of drug allergies
• • Need oxygen therapy
• • Discharged before day 2
• • Lost to follow-up
• • Withdrawn from the trial
• • Continuing in the trial but missing data
• • Meeting the criteria for psychiatric disorders other than depression and/or anxiety.